Today, CAHC signed-on to a letter in opposition to President Trump’s recent “Most Favored Nation” executive order. If implemented, the order would impose an “international pricing index” (IPI) on Medicare Part B drugs, tying American drug prices to the prices in foreign countries with government-run healthcare systems.
CAHC continues to oppose IPI-like drug pricing policies as importing government-imposed price controls and threatening patient access to treatment.